Showing results (191-200 of 205) with videos related to
Sort By:
Pageof 21
Nature Biomedical Engineering|June 19, 2024
A pathologist-AI collaboration framework for enhancing diagnostic accuracies and efficienciesZhi Huang, Eric Yang, Jeanne Shen, et al.Trials|November 16, 2021
Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristicsChristopher N Sciamanna, Noel H Ballentine, Melissa Bopp, et al.Science Advances|December 15, 2021
Single-synapse analyses of Alzheimer's disease implicate pathologic tau, DJ1, CD47, and ApoEThanaphong Phongpreecha, Chandresh R Gajera, Candace C Liu, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 21, 2023
Prediction of neuropathologic lesions from clinical dataThanaphong Phongpreecha, Brenna Cholerton, Syed Bukhari, et al.Contemporary Clinical Trials|September 28, 2018
Working to Increase Stability through Exercise (WISE): Study protocol for a pragmatic randomized controlled trial of a coached exercise program to reduce serious fall-related injuriesChristopher Sciamanna, Noel H Ballentine, Melissa Bopp, et al.Nature Genetics|September 8, 2025
Multiancestry brain pQTL fine-mapping and integration with genome-wide association studies of 21 neurologic and psychiatric conditionsAliza P Wingo, Yue Liu, Selina M Vattathil, et al.Molecular Neurodegeneration|May 15, 2025
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosisAdam N Trautwig, Edward J Fox, Eric B Dammer, et al.Nature Biotechnology|May 22, 2024
Mapping medically relevant RNA isoform diversity in the aged human frontal cortex with deep long-read RNA-seqBernardo Aguzzoli Heberle, J Anthony Brandon, Madeline L Page, et al.Biorxiv : the Preprint Server for Biology|August 23, 2023
Using deep long-read RNAseq in Alzheimer's disease brain to assess medical relevance of RNA isoform diversityBernardo Aguzzoli Heberle, J Anthony Brandon, Madeline L Page, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2021
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 studyAmit Bar-Or, Heinz Wiendl, Xavier Montalban, et al.Pageof 21